Despite the advisory, controversy remains about which symptoms of depression are most important in cardiac patients. studies [6] [7] [8] have indicated that compared with cognitive/affective symptoms, somatic/affective symptoms are more predictive of health outcomes, including mortality, in cardiac patients. However, somatic indications are confounded by health status, which mediates their relationship with poor outcomes. [6] [7] [8] In contrast, cognitive/affective symptoms may be underrecognized in cardiac patients because these symptoms are more subtle in these patients than in otherwise healthy, depressed persons. 9 In addition, cognitive/affective symptoms-but not somatic/affective symptoms-have been associated with prolonged elevation of levles of C-reactive protein, a marker of generalized inflammation, which is in turn a hallmark of CHD. 10 To date, no investigators have evaluated symptom clusters (defined as unique groups of 2 or more symptoms that occur together and are related 11 ) of depression in hospitalized CHD patients.
Evaluation of symptom clusters of depression in CHD patients can inform screening, referral, and treatment for depression. 1 For both depression and CHD, screening and diagnosis involve assessment of symptom clusters. 12, 13 Because symptom clusters for the 2 conditions may overlap, clinicians are left to attribute symptom clusters to one condition or the other (or both) without any empirical guidance. An awareness of symptom clusters associated with depression in patients with CHD may improve detection of depression by acute care clinicians and potentially improve care for CHD patients who have depression. 14 We retrospectively analyzed data on patients hospitalized because of acute CHD. We tested the following hypotheses: Mutually exclusive clusters of depressive symptoms will be present in patients with CHD who were hospitalized after an acute event, and cognitive/affective symptoms will be associated with the presence of clinical depression (major or minor depression) in these patients.
Methods
Design secondary analyses of data from 3 similar studies were conducted. The first study 15 was a pilot study of cognitive behavioral therapy in depressed women hospitalized for a cardiac event; the second was a randomized control trial 16 of the effect of cognitive behavioral therapy on immune biomarkers in cardiac surgery patients with depression; the third was a study 17 of depression screening of hospitalized cardiac patients by nurses. In each study, all patients were hospitalized for an acute coronary event, were assessed for clinical depression (ie, major depression or minor depression) by use of a structured clinical interview, and had symptoms of depression measured by use of standardized instruments.
Collectively, the studies included 323 patients in 3 large urban medical centers who met the inclusion s ymptoms of depression have been correlated with poor outcomes among patients with coronary heart disease (CHD) who have increased risk for further cardiac events after acute coronary syndrome (ACs).
1 symptoms of depression in patients after ACs have been associated with greater use of primary care services, an increased number of hospital readmissions, increased incidence of chest pain, poorer adherence to medical recommendations, 2 decreased incidence of returning to work, 3 and increased numbers of adverse health events. 4, 5 In 2008, concern about these deleterious effects led the American Heart Association, with an endorsement from the American psychiatric Association, to publish a scientific advisory 1 calling for routine screening of depression in CHD patients.
Procedure
Each primary trial had been approved by the appropriate institutional review board, and each patient had signed informed consent forms at the institution in which the patient was hospitalized. The secondary analysis was approved by the institutional review board of the University of California, Los Angeles. screening and subsequent diagnosis of depression were done before discharge from the hospital by using the instruments described in the next paragraph. Demographic and clinical data were obtained by chart review and self-report. All data were de-identified, and new identification numbers were assigned when the 3 data sets were merged.
Instruments
In the 3 parent studies, depressive symptoms were assessed by advanced practice nurses who used either the Hamilton Rating scale for Depression (HRsD) or the Beck Depression Inventory (BDI). Assessment for major or minor depression was performed by using the Depression Interview and structured Hamilton (DIsH) 19, 20 or the The structured Clinical Interview for DsM-III-R (sCID). 21 The DIsH and the sCID are structured interview tools that were administered in the parent studies by advanced practice nurses after supervised training. Both tools are commonly used as criterion standards for the diagnosis of depression, and both include modules for detection of other psychiatric disorders and for history of depression.
The DIsH was developed for use in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study 20 and was recommended by the National Heart, Lung, and Blood Institute for diagnosis of depression in research trials. 22 Its use in diagnosing the severity of depression (major, minor, dysthymia) in patients with CHD has been evaluated against the sCID 20, 22 ; the weighted k value was 0.81. In the ENRICHD study, 20 93% of diagnoses made by research nurses who used the DIsH agreed with diagnoses made by mental health clinicians (k = 0.95). The sCID is a complex instrument used to assess for Axis I mental health disorders, including depression, as set forth by the Diagnostic and Statistical Manual of Mental Disorders. 12, 21 specific depressive symptoms were assessed and measured by using the BDI or the HRsD. The BDI 23 is a self-report instrument with 21 items rated on a severity scale of 0 to 3. It is the most commonly reported measure of depression in clinical studies. 20, 21 Although the BDI was developed for use in psychiatric patients who had no physical illness, it has been evaluated in cardiac patients and its use is well criteria of the parent studies and for whom complete data were available. The sample included 73 women from the pilot study on use of cognitive behavioral therapy, 150 patients from the randomized control trial on the effect of cognitive behavioral therapy on immune biomarkers, and 100 patients from the depression screening study (Figure 1 ). In order to accommodate the large number of initial participants, the researchers in the clinical trial used a screening process, the 10-item Center for Epidemiologic studies-short Depression scale, 18 to evaluate patients before the diagnostic interview. Inclusion criteria for each parent study were similar. patients were included if they had been admitted to the hospital because of a cardiac event that required medical, surgical, or percutaneous intervention; were 18 years or older; and spoke English. patients were excluded if they had a psychiatric diagnosis other than anxiety or depression (determined via structured clinical interviews), were taking psychotropic medications other than selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors, had cognitive impairment as indicated by a score of 24 or less on the Mini-Mental state Examination. Inclusion and exclusion were based on data from chart reviews, selfreports, and administration of the Mini-Mental state Examination. All patients were enrolled from cardiac step-down units before discharge from the hospital. Had no missing data 73
Final sample 323
Had no missing data 150
Screened for depression 731
Met criteria for and completed diagnostic interview 160
Consented for trial of cognitive behavioral therapy 808
Consented for screening study 101
Consented for women's study 75
Secondary analyses of data from 3 similar studies were conducted.
accepted. 2, 6, 22, 25, 26 The HRsD is a 17-item observer rating tool with various response scales. It has been widely used in medical patients. 19, 20 For the secondary analysis, variables consistent with commonly measured symptoms of depression were selected from the BDI and HRsD. A panel of content experts formed for this study, 5 experienced mental health advanced practice nurses who participated in the evaluation of the 2 tools, compressed the 21 items on the BDI and the 17 items on the HRsD into the following 11 transformed variables: anhedonia (loss of interest or pleasure in activities), dysphoria (feeling sad, depressed, empty), loss of appetite (loss of perceived desire for food or drink), sleep disturbance (interference with sleep), fatigue (physical or mental weariness), guilt (an awareness of having done wrong, accompanied by shame or regret), suicidal symptoms (thoughts of ending one's life with some degree of intent), hypochondriasis (morbid concern about one's health), loss of libido (perceived loss of interest in sex), psychomotor impairment (a slowing down of thoughts and/or movements), and nervous irritability (state of excitability, with mental or physical unrest; edginess). symptoms that are not part of the Diagnostic and Statistical
Manual of Mental Disorders (Fourth Edition, Text Revision)
12 diagnostic (ie, hypochondriasis, nervous irritability) were included because they are commonly assessed in screening and treatment-response measures. Each transformed symptom variable was scored as follows: no symptoms, 0; minimal symptoms, 1; moderate symptoms, 2; and severe symptoms, 3. The same panel of content experts evaluated the transformed variables for equivalence to the BDI and HRsD in item construct and severity by using a 4-point scale (0 = strongly disagree to 4 = strongly agree) for each of the 11 variables. Consensus was reached when 3 or more of the 5 experts scored the variable as 3 or more on the 4-point scale.
Analysis
Data were analyzed by using spss predictive Analytics softWare statistics 18.0 (spss IBM). Frequencies and means were computed to summarize sample characteristics. Categorical variables were compared by using c 2 analysis, and continuous variables were compared by using a t test.
Hierarchical cluster analysis was performed to partition groups of similar symptoms (agglomerative method) on the basis of the Euclidean distance in the sample axis of a proximity matrix. 27 The Ward method was used to measure distances between clusters in an analysis-of-variance approach in which the sum of squares of any 2 clusters is minimized. 27 The proximity matrix was used to develop a tree-based dendrogram to pictorialize the clusters. A 3-cluster solution was chosen on the basis of similar statistical distances and even separation of the clusters on the dendrogram. 27 Finally, logistic regression was used to evaluate the association of symptom clusters with presence or absence of depression. Each of the 3 symptom clusters was included as a binary variable (present/not present). Demographic and clinical variables correlated with presence/absence of clinical depression at P ≤ .10 (Table 1) were entered into the regression in a first block, with the 3 symptom clusters entered separately in a second block. goodness of fit of the model was evaluated by using the HosmerLemeshow statistic. simple forced entry was used. significance was set at P < .05.
Results

Sample Characteristics
Demographic and clinical characteristics of the sample are presented in Table 1 . Of the 323 participants in the study, 99 (31%) were depressed (major or minor depression) according to the results of the structured interview. The sample had 151 women (47%) and 172 men (53%). The prevalence of depression did not differ significantly by sex (54% for women and 46% for men; P = .10). ACs was diagnosed in 203 patients (63%). patients with ACs were less likely to be depressed than were those who had not experienced ACs as part of the hospital admission (P = .02). Age, marital status, ethnicity, smoking, use of medications, body mass index, and type of procedure did not differ significantly between patients who were depressed and patients who were not. patients with depression were more likely (P = .01) to have a selfreported history of depression (35%) than were patients who were not depressed (22%).
Fatigue (69%) and sleep disturbance (55%) were the most prevalent depressive symptoms; guilt (25%) and suicidal symptoms (9%) were the least common ( Figure 2 ). Compared with patients who were not depressed, patients who were depressed had higher scores for anhedonia, dysphoria, loss of appetite, sleep disturbance, fatigue, guilt, loss of libido, and nervous irritability (P < .001 for all symptoms; Patients with acute coronary syndrome were less likely to be depressed than those without ACS.
depression in the logistic model that also included the other 2 symptom clusters, sex, and history of depression (Table 4) . patients in the cognitive/affective cluster were 1.41 times more likely to be depressed than were patients not in this cluster (P < .001; 95% CI, 1.223-1.631). patients who experienced ACs at the time of admission were less likely to be depressed than were patients with CHD who were admitted without ACs (odds ratio, 0.446; P = .004; 95% CI, 0.255-0.778).
Discussion
Assessment and diagnosis of depression in patients with CHD are complicated by the presence
Symptom Clusters
Three clusters were identified (Figure 3 ) from the symptom variables proximity matrix (Table 3) . Cluster 1 (cognitive/affective symptoms) included anhedonia, dysphoria, guilt, suicidal symptoms, and nervous irritability. Cluster 2 (somatic/affective) included loss of appetite, hypochondriasis, loss of libido, and psychomotor impairment. Cluster 3 (somatic symptoms) included sleep disturbance and fatigue. The names assigned to the clusters are consistent with the existing literature on depressive symptom contructs. 6, 7 Only the cognitive/affective cluster and presence /absence of ACs were independently associated with of confounding somatic, cognitive, and affective symptoms. 6, 7 In this study, we identified 3 unique symptom clusters (cognitive/affective, somatic/affective, and somatic) that may aid clinicians in targeting patients with CHD who are most likely to be depressed. Our use of cluster analysis enabled us to identify mutually exclusive clusters, with minimal homogeneity between clusters and maximum homogeneity within clusters. 
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Total Depressed Not depressed Symptom (N = 323) (n = 99) (n = 234) P a by guest on March 6, 2014 ajcc.aacnjournals.org Downloaded from indicate that cognitive/affective symptoms are important because the symptoms distinguish patients who are depressed from patients who are not in a situation in which somatic/affective symptoms are ubiquitous. Cognitive/affective symptoms can be easily overlooked or misconstrued as part of poor somatic health, which often occurs in patients with acute cardiac events. Thus, clinicians caring for hospitalized patients with CHD should pay particular attention to the cognitive/ affective symptoms of anhedonia and blue mood.
A key finding of our study is that in patients hospitalized because of CHD, only the cognitive/affective symptom cluster (ie, anhedonia, dysphoria) is associated with clinical depression. These findings favor initial depression screening of patients with instruments that focus on cognitive symptoms of depression, such as the patient Health Questionnaire-2 (pHQ-2). [29] [30] [31] Other investigations of depressive symptoms in cardiac patients have differed from our study in 2 ways. First, the researchers used factor analysis or principal component analysis, which does not produce discrete groups of symptoms. 6, 7, 28 second, previous investigations have focused on cardiovascular prognosis, not depression screening. Interestingly, these reports 6, 7, 28 have emphasized the importance of somatic/affective, rather than cognitive/affective, symptoms of depression. somatic/affective symptoms may be useful in predicting CHD prognosis because they are associated with atherosclerosis as well as depression. Thus, the association of somatic/ affective symptoms with prognosis may be mediated in part by the underlying disease process. 28 Conversely, because we focused on depression screening rather than on prognosis, our findings If either of the cognitive/affective symptoms is present, then the full pHQ-9, which includes both cognitive/affective and somatic/affective symptoms, is recommended for further assessment. 1 An added advantage of using the pHQ-2 for initial screening is that little time is required, and thus the burden to patients or caregivers is decreased. In summary, our findings suggest that identification of cognitive/affective and somatic/affective symptoms may have complementary uses for clinicians. Although other investigators have shown that somatic/affective symptoms are important for prognosis, our findings indicate that cognitive/affective symptoms are important for screening.
Further support for our finding that cognitive/ affective symptoms are unique correlates of depression 12 and by using an objective expert panel of 5 independent mental health nursing professionals. Oversampling of women, because 1 parent study included only women, may have created a selection bias based on sex. Use of a convenience sample and the lack of information about the number of eligible patients who did not participate in the parent studies limit external validity and inferences that can be drawn from our findings. The sample consisted of a variety of cardiac patients admitted for a procedure related to CHD, a situation that might confound symptoms. However, we did not find any statistical difference in depression symptoms in our sample. These limitations notwithstanding, a significant strength of our findings is that all patients were evaluated for depression by using a structured interview, the standard criterion for the diagnosis of depression
Conclusion
Improvement in detecting depression in patients with CHD who are hospitalized has been a focus of researchers since the scientific advisory 1 was published by the American Heart Association in 2008. The overlapping of somatic, cognitive, and affective symptoms in patients with CHD creates complexity in symptom assessment and diagnosis. Because clinicians may be more focused on somatic symptoms in the context of heart disease, they may overlook cognitive symptoms of depression. Our findings suggest that clinicians caring for patients with CHD who are hospitalized should pay particular attention to the same cognitive/affective symptoms of anhedonia and blue mood that occurs in patients without CHD who are depressed. Heightened awareness of this cognitive/affective symptom cluster in hospitalized CHD patients may improve detection of depression and may facilitate further assessment, referral, and treatment. 12 in which major depression is defined as a significant mood change that includes 1 or both of the 2 primary symptoms: anhedonia and low mood. In our study, the symptoms that form the somatic/affective cluster (loss of appetite, hypochondriasis, loss of libido, and psychomotor impairment) and those that form the somatic cluster (sleep disturbance and fatigue) represent symptoms of depressive disorders. However, cognitive/affective symptoms, such as those in the cognitive/affective cluster, must accompany these somatic symptoms before a condition can be diagnosed as depression. 12 Thus, our findings are consistent with the diagnostic criteria for clinical depression.
When we considered clusters in multivariate analyses, we found that absence of ACs was the only variable independently associated with depression other than the presence of cognitive/affective symptoms (Table 4) . possibly, either patients with ACs or patients without the syndrome had greater experience with cardiac symptoms, a situation that could have influenced the different rates of depression in the 2 groups, because chronic heart disease is associated with greater rates of depression than is newonset disease. 33 We did not assess the occurrence of previous cardiac events or the duration of CHD in our sample. Thus, we cannot examine the influence of living with CHD on rates of depression in our patients. In addition, a history of depression was a significant correlate of depression according to the multivariate analysis. The percentages of patients with and without depression who had histories of depression were within the wide range (27%-67%) reported in other studies. [34] [35] [36] [37] Further study is needed to asssess the differences in cognitive/affective symptoms of depression in ACs patients compared with chronic CHD patients and the relationship of a history of depression to the rate of depression in both populations.
Limitations
Our use of a combined secondary data set derived from the data of 3 other research studies may have affected the internal validity of the data. In the 3 parent studies, 2 separate structured clinical interviews were used. Also, in 2 of the parent studies, the researchers used the BDI to assess depressive symptoms, whereas the HRsD was used in the third. For the clinical interviews, the possible lack of internal validity in our study due to the instruments we used was mitigated by the use in the parent studies of a panel of mental health clinicians to adjudicate clusters are associated with clinical depression among hospitalized CHD patients. A total of 323 hospitalized CHD patients were enrolled into 1 of 3 parent studies and screened for depressive symptomatology with the Hamilton Rating Scale for Depression or the Beck Depression Inventory.
Prior to data analysis, a panel of mental health advanced practice nurses convened to transform the 2 measures of depressive symptoms into 11 symptom variables representative of the diagnostic criteria for depression cited in the Diagnostic and Statistical Manual of Mental Disorders-IV. This study confirmed that fatigue and sleep disturbance were the most prevalent symptoms among hospitalized CHD patients. Three clusters of symptoms were identified. However, CHD patients who classified as experiencing the cognitive/affective symptom cluster, which consists of symptoms of anhedonia, dysphoria, guilt, suicidal ideation, and nervous irritability, were more likely to meet the diagnostic criteria for clinical depression when compared to individuals classified into the somatic/affective or somatic symptom clusters. The results of this study underscore the need to engage in routine depression screening and that the presentation of symptoms associated with the cognitive/affective cluster should inform clinicians to refer hospitalized CHD patients for further evaluation and treatment for depression.
Information From the Authors
Anthony McGuire, RN, PhD, ACNP-BC, CCRN, lead author on this research article provides additional information about the study. He believes his passion for critically ill cardiac patients and his inquisitive nature were pivotal in his interest to develop a research
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A nthony McGuire, RN, PhD, ACNP-BC, CCRN, is currently an assistant professor at the California State University, Long Beach, School of Nursing. He has more than 20 years of critical care and emergency nursing experience and is a fellow of the American Heart Association. He and his coauthors take a multidisciplinary approach to identifying symptom clusters associated with clinical depression in hospitalized CHD patients. McGuire's research interest is the identification of depressive symptoms among patients with CHD.
When reflecting on his experience conducting this research, McGuire states, "A significant challenge was to get the 'buy in' from the nursing staff on the intensive care unit." He notes that nurses at the beside are busy and adding one more thing to their plate is not always welcomed. However, he says education and positive reinforcement were helpful in getting the nursing staff to understand the importance of this work.
Despite the exploratory nature of this study, the research done by McGuire and his coauthors provides evidence that supports further investigation into the screening and management of clinical depression in hospitalized CHD patients. McGuire and his coauthors note that detection of clinical depression in this context is challenging but they encourage clinicians to increase their suspicion for clinical depression when hospitalized CHD patients show symptoms associated with the cognitive/affective cluster. D epressive symptoms in hospitalized patients with coronary heart disease (CHD) are underrecognized and associated with an increased risk for adverse cardiovascular events. In 2008, the American Heart Association and the American Psychiatric Association published a scientific advisory calling for the routine screening for depression in patients living with CHD.
In response to this national scientific priority, this secondary data analysis notes that symptom
